Runben Biotechnology Co., Ltd. (SHA:603193)
China · Delayed Price · Currency is CNY 17.04
-0.29 (-1.67%)
Oct 29, 2026, 2:04 PM CST
Runben Biotechnology Market Cap
Runben Biotechnology has a market cap or net worth of 6.89 billion as of October 28, 2026. It is the 9,798th most valuable company in the world and the 2,164th biggest in China. Its market cap has decreased by 35.77% in one year.
Market Cap
6.89B
Enterprise Value
5.45B
Revenue
1.71B
Global Rank
Country Rank
#2,164 China
PE Ratio
19.80
ChartMarket Cap Chart
Since October 17, 2023, Runben Biotechnology's market cap has decreased from 8.93B to 6.89B, a decrease of -22.83%. That is a compound annual growth rate of -8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 6.89B | -29.67% |
| Dec 31, 2025 | 9.80B | 3.77% |
| Dec 31, 2024 | 9.45B | 28.44% |
| Dec 29, 2023 | 7.36B | -17.66% |
| Oct 17, 2023 | 8.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yunnan Botanee Bio-Technology Group Co.LTD | 13.66B |
| Shanghai Jahwa United | 12.18B |
| Guangdong Marubi Biotechnology | 10.13B |
| Chongqing Baiya Sanitary Products | 9.76B |
| C&S Paper Co.,Ltd | 8.64B |
| Dencare (Chongqing) Oral Care | 5.79B |
| Tongling Jieya Biologic Technology | 5.40B |
| Hangzhou Haoyue Personal Care | 5.39B |